Evidence map›Paper›PMID 39164233›Full record

Observational studyNature communications2024

A Platelet Reactivity ExpreSsion Score derived from patients with peripheral artery disease predicts cardiovascular risk.

Jeffrey S Berger, Macintosh G Cornwell, Yuhe Xia, Matthew A Muller, Nathaniel R Smilowitz, Jonathan D Newman, Florencia Schlamp, Caron B Rockman, Kelly V Ruggles, Deepak Voora and 2 more

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02106429 (Platelet Activity in Vascular Surgery and Cardiovascular Events), which is not on this map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02106429 completednot on this map

Platelet Activity in Vascular Surgery and Cardiovascular Events

TypeobservationalSponsorNYU Langone HealthRan2014 to 2018Enrolled246ConditionsCardiovascular Disease, Peripheral Artery Disease, Critical Limb Ischemia
3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Article
  3. Arteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Platelet reactivity expression score in diabetes mellitus.Blood vessels, thrombosis & hemostasis · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Platelet pals: How blood cells shape the future of the aorta.Vascular medicine (London, England) · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jeffrey S BergerDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA. Jeffrey.Berger@nyulangone.org.ORCID 0000-0001-8216-4647
Macintosh G CornwellDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.
Yuhe XiaDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.
Matthew A MullerDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.
Nathaniel R SmilowitzDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.
Jonathan D NewmanDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0001-6855-7305
Florencia SchlampDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.
Caron B RockmanDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.
Kelly V RugglesDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0002-0152-0863
Deepak VooraDepartment of Medicine, Duke Center for Applied Genomics & Precision Medicine, Duke University School of Medicine, Durham, NC, USA.
Judith S HochmanDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA.ORCID 0000-0002-5889-5981
Tessa J BarrettDepartment of Medicine, New York University Grossman School of Medicine, New York, NY, USA. Tessa.Barrett@nyulangone.org.

Funding

Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MARK Reid PHILIPS · 1985 to 2026
$83.1M
Mechanisms of Platelet Activity in Vascular DiseaseR35HL144993 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BERGER, JEFFREY S · 2019 to 2025
$5.5M
Development Of Prognostic Platelet RNA Biomarkers To Tailor Antiplatelet TherapyR01HL118049 · NHLBI · DUKE UNIVERSITY · PI VOORA, DEEPAK · 2013 to 2017
$3.9M
Platelet Activity & Cardiovascular Events following Vascular SurgeryR01HL114978 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BERGER, JEFFREY S · 2013 to 2017
$3.0M
CD37 as a Regulator of Platelet Patho(Physiological) ResponsesR01HL167917 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Tessa Barrett · 2023 to 2026
$2.3M
Mechanisms of Coronary Microvascular DiseaseK23HL150315 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SMILOWITZ, NATHANIEL ROSSO · 2020 to 2024
$948k
NCATS NIH HHS UL1 TR001445NCI NIH HHS P30 CA016087NHLBI NIH HHS K23 HL150315NHLBI NIH HHS R01 HL114978NHLBI NIH HHS R01 HL118049NHLBI NIH HHS R01 HL167917NHLBI NIH HHS R35 HL144993
6 · The paper itself

Abstract

Platelets are key mediators of atherothrombosis, yet, limited tools exist to identify individuals with a hyperreactive platelet phenotype. In this study, we investigate the association of platelet hyperreactivity and cardiovascular events, and introduce a tool, the Platelet Reactivity ExpreSsion Score (PRESS), which integrates platelet aggregation responses and RNA sequencing. Among patients with peripheral artery disease (PAD), those with a hyperreactive platelet response (>60% aggregation) to 0.4 µM epinephrine had a higher incidence of the 30 day primary cardiovascular endpoint (37.2% vs. 15.3% in those without hyperreactivity, adjusted HR 2.76, 95% CI 1.5-5.1, p = 0.002). PRESS performs well in identifying a hyperreactive phenotype in patients with PAD (AUC [cross-validation] 0.81, 95% CI 0.68 -0.94, n = 84) and in an independent cohort of healthy participants (AUC [validation] 0.77, 95% CI 0.75 -0.79, n = 35). Following multivariable adjustment, PAD individuals with a PRESS score above the median are at higher risk for a future cardiovascular event (adjusted HR 1.90, CI 1.07-3.36; p = 0.027, n = 129, NCT02106429). This study derives and validates the ability of PRESS to discriminate platelet hyperreactivity and identify those at increased cardiovascular risk. Future studies in a larger independent cohort are warranted for further validation. The development of a platelet reactivity expression score opens the possibility for a personalized approach to antithrombotic therapy for cardiovascular risk reduction.

Indexed as

Blood PlateletsCardiovascular DiseasesPeripheral Arterial DiseasePlatelet AggregationAgedEpinephrineFemaleHeart Disease Risk FactorsHumansMaleMiddle AgedPlatelet ActivationRisk FactorsEpinephrine

Identifiers

PMID39164233
PMCPMC11336089

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.